Dr. Rachel Kang, MD

Dr. Rachel Kang is a highly skilled dermatologist with an impressive background in complex medical dermatology and oncodermatology. Patients consistently commend her compassionate care and individualized approach to providing her patients comprehensive treatment plans.

Dr. Kang completed her dermatology residency and postdoctoral residency fellowship at New York-Presbyterian Hospital, where she was celebrated for her clinical excellence and leadership. Dr. Kang began her medical education at Cornell University, earning her BA, and went on to receive her MD from Weill Cornell Medical College, where she was honored for Excellence in Research. She also completed her preliminary year in Internal Medicine at Pennsylvania Hospital, where she was recognized for her outstanding performance. Dr. Kang is an Assistant Professor of Clinical Dermatology at Weill Cornell Medical College.

Professional Associations Dr. Kang is an active member of several professional associations, including:

• Society for Pediatric Dermatology
• American Academy of Dermatology (AAD)
• American Society for Dermatologic Surgery
• Women’s Dermatologic Society
• American Medical Association
• New York Korean American Medical Association

Innovation & Research Dr. Kang has an extensive background in innovation and research, with a particularly focus on dermatology and oncology. She has contributed significantly to various research initiatives, including her work with the Atkins Foundation Summer Research Fellowship and the Sandra and Edward Meyer Cancer Center. Dr. Kang's research encompasses the role of phosphatidylinositol 5-phosphate 4-kinase beta in lipolysis and the development of CRISPR-based immunotherapy for hematologic malignancies. Her work has been published in esteemed journals, highlighting her contributions to understanding and treating complex skin conditions and skin cancers. Dr. Kang has presented her groundbreaking findings at numerous national and international conferences, reflecting her commitment to advancing both dermatological care and oncology.

Selected Publications

• Kang R, Lipner S. Consumer Preferences of Antifungal Products for Treatment and Prevention of Tinea Pedis. Journal of Dermatological Treatment. 2019 Jan; 21:1-17.
• Kang R, Lipner S. Evaluation of Onychomycosis Information on the Internet. Journal of Drugs in Dermatology. 2019 May; 18(5):484
• Kang R, Lipner S. Social Media and Dissemination: Impressions of Fish Pedicures Following a Case of Onychomadesis. Dermatology Online Journal. 2020 Mar; Pub Status: In-Press
• Hoellwarth J, Reif T, Mori S, Kang R, Magro C. Horrifying Basal Cell Carcinoma Presenting As Progressive Pyoderma Gangrenosum. Case Reports in Oncology. 2024, Feb; 17(1): 298-304
• Perez R, Kang R, Chen R, Castellanos J, Milewski A, Perez A. Computational Oncology. Journal of Oncopathology and Clinical Research. 2018, Mar; 2(1): 3.
• Perez RK, Chen R, Kang R, Perez AR. Advent of CRISPR Based Immunotherapy in Hematologic Malignancies. Journal of Oncopathology and Clinical Research. 2018, Mar; 2(1): 2.